Vcreate, Inc.
MENLO PARK, CA · Biotech · Private
High-throughput platform for screening T-cell receptors (TCRs) against antigens to identify functional TCR-antigen pairs using engineered T-macrophages and single-cell sequencing readout
- Grants
- $1.7M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 1 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Computational algorithm to predict interacting MHC alleles from TCR sequences | $256,581 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I:High throughput and antigen specific T-cell receptor discovery through engineered macrophages | $256,000 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: High throughput and antigen specific T-cell receptor discovery for solid tumor treatments | $1,207,999 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1374 | KAPS BIOTECH, INC. | — | — |
| 1375 | LAUREN SCIENCES, LLC | — | — |
| 1376 | HELIXOMER, INC. | — | — |
| 1377 | Vcreate, Inc. | — | — |
| 1378 | YASO THERAPEUTICS INCORPORATED | — | — |
| 1379 | CHIMERNA THERAPEUTICS, INC. | — | — |
| 1380 | Monopar Therapeutics | — | $2.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions and Methods for Making Novel T-Cell Receptorsgranted
- Methods For Finding Novel T-cell Receptorsapplication
- Novel T-cell Receptor and Uses Thereofapplication
- Methods for Finding Novel T-cell Receptorsapplication
- Compositions And Methods For Making Novel T-cell Receptorsapplication
- Compositions and Methods for Making Novel Cell Receptorsapplication
- Compositions and Methods for Making Novel T-cell Receptorsapplication
- Compositions and Methods for Making Novel T-cell Receptorsapplication
- A Novel T-cell Receptor And Uses Thereofapplication
- A Novel T-cell Receptor and Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.